These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 3013941

  • 1. Normalization of hypercalcemia associated with a decrease in renal calcium reabsorption in Leydig cell tumor-bearing rats treated with WR-2721.
    Hirschel-Scholz S, Caverzasio J, Rizzoli R, Bonjour JP.
    J Clin Invest; 1986 Jul; 78(1):319-22. PubMed ID: 3013941
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.
    Hirschel-Scholz S, Caverzasio J, Bonjour JP.
    J Clin Invest; 1985 Nov; 76(5):1851-6. PubMed ID: 2997292
    [Abstract] [Full Text] [Related]

  • 3. Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats.
    Rizzoli R, Caverzasio J, Fleisch H, Bonjour JP.
    Endocrinology; 1986 Sep; 119(3):1004-9. PubMed ID: 3755393
    [Abstract] [Full Text] [Related]

  • 4. Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats.
    Rizzoli R, Caverzasio J, Chapuy MC, Martin TJ, Bonjour JP.
    J Bone Miner Res; 1989 Oct; 4(5):759-65. PubMed ID: 2554691
    [Abstract] [Full Text] [Related]

  • 5. Humoral hypercalcemia caused by a rat Leydig-cell tumor is associated with suppressed parathyroid hormone secretion and increased urinary cAMP excretion.
    Spiegel AM, Saxe AW, Deftos LJ, Brennan MF.
    Horm Metab Res; 1983 Jun; 15(6):299-304. PubMed ID: 6307850
    [Abstract] [Full Text] [Related]

  • 6. Management of hypercalcemia in relation to pathophysiology.
    Bonjour JP, Rizzoli R, Hirschel-Scholz S, Caverzasio J.
    Bone; 1987 Jun; 8 Suppl 1():S29-33. PubMed ID: 2825740
    [Abstract] [Full Text] [Related]

  • 7. Interference of WR-2721 with magnesium metabolism: mechanism of action.
    Hirschel-Scholz S, Paunier L, Bonjour JP.
    Miner Electrolyte Metab; 1988 Jun; 14(2-3):114-20. PubMed ID: 2837628
    [Abstract] [Full Text] [Related]

  • 8. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls.
    Henderson J, Bernier S, D'Amour P, Goltzman D.
    Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of humoral hypercalcemia of malignancy in rats with inhibitors of carbonic anhydrase.
    Brown GM, Morris CA, Mitnick MA, Insogna KL.
    J Bone Miner Res; 1990 Oct; 5(10):1037-41. PubMed ID: 1964358
    [Abstract] [Full Text] [Related]

  • 11. Hypocalcaemic effect of WR-2721, S-2 (3-aminopropylamino) ethyl-phosphorothioic acid in an anuric haemodialysis patient.
    Zingraff J, Bourdeau A, Clair F, Kindermans C, Buisson C, Manganella G, Sachs C, Drüeke T.
    Nephrol Dial Transplant; 1987 Oct; 2(1):48-52. PubMed ID: 3037448
    [Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M, Yates AJ, Garrett IR, Chavez J, Dunn JF, Bonewald L, Mundy GR.
    Lab Invest; 1990 Nov; 63(5):676-82. PubMed ID: 2232714
    [Abstract] [Full Text] [Related]

  • 14. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M, Kremer R, Goltzman D, Rabbani SA.
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [Abstract] [Full Text] [Related]

  • 15. Stimulation by interleukin-1 of renal calcium reabsorption in thyroparathyroidectomized rats.
    Caverzasio J, Rizzoli R, Vallotton MB, Dayer JM, Bonjour JP.
    J Bone Miner Res; 1993 Oct; 8(10):1219-25. PubMed ID: 8256659
    [Abstract] [Full Text] [Related]

  • 16. Prevention of parathyroid hormone-dependent nephrocalcinosis by chronic administration of the organic phosphorothioate WR-2721.
    Hirschel-Scholz S, Caverzasio J, Bonjour JP.
    Calcif Tissue Int; 1987 Feb; 40(2):103-8. PubMed ID: 3032378
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma.
    Hirschel-Scholz S, Jung A, Fischer JA, Trechsel U, Bonjour JP.
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):313-8. PubMed ID: 3000652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.